Caroline R. Young's most recent trade in Cumberland Pharmaceuticals Inc. was a trade of 5 Common Stock done at an average price of $4 . Disclosure was reported to the exchange on Dec. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 5 | 33,309 (0%) | 0% | 4 | 20 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 4 | 33,263 (0%) | 0% | 2.3 | 9 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 4 | 33,259 (0%) | 0% | 2.3 | 9 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 4 | 33,255 (0%) | 0% | 2.3 | 9 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 4 | 33,251 (0%) | 0% | 2.3 | 9 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 4 | 33,247 (0%) | 0% | 2.3 | 9 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 3 | 33,287 (0%) | 0% | 3.7 | 11 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 3 | 33,290 (0%) | 0% | 4.3 | 13 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 3 | 33,284 (0%) | 0% | 3.3 | 10 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 3 | 33,281 (0%) | 0% | 2.7 | 8 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 3 | 33,278 (0%) | 0% | 2.7 | 8 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 3 | 33,275 (0%) | 0% | 2.7 | 8 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 3 | 33,272 (0%) | 0% | 2.7 | 8 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 3 | 33,269 (0%) | 0% | 2.3 | 7 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 3 | 33,266 (0%) | 0% | 2.3 | 7 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 2 | 33,304 (0%) | 0% | 4 | 8 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 2 | 33,302 (0%) | 0% | 4 | 8 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 2 | 33,300 (0%) | 0% | 4 | 8 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 2 | 33,298 (0%) | 0% | 4.5 | 9 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 2 | 33,296 (0%) | 0% | 4 | 8 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 2 | 33,294 (0%) | 0% | 4.5 | 9 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 01 Dec 2025 | 2 | 33,292 (0%) | 0% | 4 | 8 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 6 | 33,174 (0%) | 0% | 2.8 | 17 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 6 | 33,186 (0%) | 0% | 2.5 | 15 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 6 | 33,180 (0%) | 0% | 2.8 | 17 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 4 | 33,243 (0%) | 0% | 2.5 | 10 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 4 | 33,239 (0%) | 0% | 2.3 | 9 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 4 | 33,235 (0%) | 0% | 2.3 | 9 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 4 | 33,231 (0%) | 0% | 2 | 8 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 4 | 33,227 (0%) | 0% | 2 | 8 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 4 | 33,223 (0%) | 0% | 2 | 8 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 4 | 33,219 (0%) | 0% | 2 | 8 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 4 | 33,215 (0%) | 0% | 2 | 8 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 4 | 33,211 (0%) | 0% | 2.3 | 9 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 3 | 33,207 (0%) | 0% | 2 | 6 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 3 | 33,204 (0%) | 0% | 2.3 | 7 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 3 | 33,201 (0%) | 0% | 2 | 6 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 3 | 33,198 (0%) | 0% | 2 | 6 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 3 | 33,195 (0%) | 0% | 2 | 6 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 3 | 33,192 (0%) | 0% | 2.3 | 7 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 03 Nov 2025 | 3 | 33,189 (0%) | 0% | 2.3 | 7 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 6 | 33,024 (0%) | 0% | 3.2 | 19 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 6 | 33,030 (0%) | 0% | 3.2 | 19 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 32,946 (0%) | 0% | 3.5 | 14 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 32,950 (0%) | 0% | 3.5 | 14 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 32,954 (0%) | 0% | 3.5 | 14 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 32,958 (0%) | 0% | 3.5 | 14 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 32,962 (0%) | 0% | 3.5 | 14 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 32,966 (0%) | 0% | 3.5 | 14 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 32,970 (0%) | 0% | 3.5 | 14 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 32,974 (0%) | 0% | 3.5 | 14 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 32,978 (0%) | 0% | 3.5 | 14 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 32,982 (0%) | 0% | 3.5 | 14 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 32,986 (0%) | 0% | 3.5 | 14 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 32,990 (0%) | 0% | 3.5 | 14 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 32,994 (0%) | 0% | 3.3 | 13 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 32,998 (0%) | 0% | 3.3 | 13 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 33,002 (0%) | 0% | 3.3 | 13 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 33,006 (0%) | 0% | 3.3 | 13 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 33,010 (0%) | 0% | 3 | 12 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 33,014 (0%) | 0% | 3 | 12 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | 02 Sep 2025 | 4 | 33,018 (0%) | 0% | 3 | 12 | Common Stock | |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 01 Aug 2025 | 6 | 32,827 (0%) | 0% | 3.5 | 21 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 01 Aug 2025 | 6 | 32,942 (0%) | 0% | 3.5 | 21 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 01 Aug 2025 | 6 | 32,936 (0%) | 0% | 3.5 | 21 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 01 Aug 2025 | 6 | 32,930 (0%) | 0% | 3.5 | 21 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.33 per share. | 01 Aug 2025 | 6 | 32,924 (0%) | 0% | 3.3 | 20 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.33 per share. | 01 Aug 2025 | 6 | 32,918 (0%) | 0% | 3.3 | 20 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.33 per share. | 01 Aug 2025 | 6 | 32,912 (0%) | 0% | 3.3 | 20 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.33 per share. | 01 Aug 2025 | 6 | 32,906 (0%) | 0% | 3.3 | 20 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.17 per share. | 01 Aug 2025 | 6 | 32,899 (0%) | 0% | 3.2 | 19 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.17 per share. | 01 Aug 2025 | 6 | 32,893 (0%) | 0% | 3.2 | 19 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 01 Aug 2025 | 6 | 32,887 (0%) | 0% | 3 | 18 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 2.83 per share. | 01 Aug 2025 | 6 | 32,881 (0%) | 0% | 2.8 | 17 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 01 Aug 2025 | 6 | 32,875 (0%) | 0% | 3 | 18 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 2.83 per share. | 01 Aug 2025 | 6 | 32,869 (0%) | 0% | 2.8 | 17 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 2.83 per share. | 01 Aug 2025 | 6 | 32,863 (0%) | 0% | 2.8 | 17 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.33 per share. | 01 Aug 2025 | 6 | 32,857 (0%) | 0% | 3.3 | 20 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.17 per share. | 01 Aug 2025 | 6 | 32,851 (0%) | 0% | 3.2 | 19 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.33 per share. | 01 Aug 2025 | 6 | 32,845 (0%) | 0% | 3.3 | 20 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 01 Aug 2025 | 6 | 32,839 (0%) | 0% | 4 | 24 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 01 Aug 2025 | 6 | 32,833 (0%) | 0% | 4 | 24 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 01 Aug 2025 | 1 | 32,900 (0%) | 0% | 3 | 3 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 01 Jul 2025 | 8 | 32,661 (0%) | 0% | 3.5 | 28 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.62 per share. | 01 Jul 2025 | 8 | 32,757 (0%) | 0% | 3.6 | 29 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.88 per share. | 01 Jul 2025 | 8 | 32,749 (0%) | 0% | 3.9 | 31 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.75 per share. | 01 Jul 2025 | 8 | 32,741 (0%) | 0% | 3.8 | 30 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 01 Jul 2025 | 8 | 32,733 (0%) | 0% | 3.5 | 28 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 01 Jul 2025 | 8 | 32,725 (0%) | 0% | 3.5 | 28 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 01 Jul 2025 | 8 | 32,773 (0%) | 0% | 3.5 | 28 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.25 per share. | 01 Jul 2025 | 8 | 32,717 (0%) | 0% | 3.3 | 26 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.25 per share. | 01 Jul 2025 | 8 | 32,709 (0%) | 0% | 3.3 | 26 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 01 Jul 2025 | 8 | 32,701 (0%) | 0% | 3 | 24 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 01 Jul 2025 | 8 | 32,693 (0%) | 0% | 3 | 24 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.25 per share. | 01 Jul 2025 | 8 | 32,685 (0%) | 0% | 3.3 | 26 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 01 Jul 2025 | 8 | 32,677 (0%) | 0% | 3.5 | 28 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 01 Jul 2025 | 8 | 32,781 (0%) | 0% | 3.5 | 28 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 01 Jul 2025 | 8 | 32,789 (0%) | 0% | 3.5 | 28 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.38 per share. | 01 Jul 2025 | 8 | 32,797 (0%) | 0% | 3.4 | 27 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 01 Jul 2025 | 8 | 32,765 (0%) | 0% | 3.5 | 28 | Common Stock |
| Cumberland Pharma Inc | Caroline R. Young | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 01 Jul 2025 | 8 | 32,669 (0%) | 0% | 3.5 | 28 | Common Stock |